Cisplatin
- Generic Name
- Cisplatin
- Brand Names
- Platinol
- Drug Type
- Small Molecule
- Chemical Formula
- Cl2H6N2Pt
- CAS Number
- 15663-27-1
- Unique Ingredient Identifier
- Q20Q21Q62J
- Background
Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
- Indication
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
- Associated Conditions
- Advanced Ovarian Cancer, Ovarian Cancer Metastatic, Advanced Bladder cancer, Advanced Testicular cancer, Metastatic Testicular cancer
- Associated Therapies
- -
S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
- Conditions
- Interventions
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 46
- Registration Number
- NCT00062439
- Locations
- 🇺🇸
Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, United States
🇺🇸Holland Community Hospital, Holland, Michigan, United States
🇺🇸Providence Cancer Institute at Providence Hospital - Southfield Campus, Southfield, Michigan, United States
Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
- Conditions
- Interventions
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2017-07-06
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 55
- Registration Number
- NCT00062374
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2010-02-12
- Lead Sponsor
- Fox Chase Cancer Center
- Registration Number
- NCT00062322
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2015-10-08
- Lead Sponsor
- University of Alabama at Birmingham
- Registration Number
- NCT00062270
- Locations
- 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
- Conditions
- Locations
- 🇳🇱
Academisch Medisch Centrum, Amsterdam, Netherlands
🇳🇱University Hospital - Rotterdam Dijkzigt, Rotterdam, Netherlands
🇳🇱Rotterdam Cancer Institute, Rotterdam, Netherlands
UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
- Conditions
- First Posted Date
- 2003-05-30
- Last Posted Date
- 2010-01-15
- Lead Sponsor
- City of Hope Medical Center
- Registration Number
- NCT00006464
- Locations
- 🇺🇸
City of Hope Medical Group, Pasadena, California, United States
🇺🇸Norris Cotton Cancer Center, Lebanon, New Hampshire, United States
🇺🇸USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer
- Conditions
- First Posted Date
- 2003-05-21
- Last Posted Date
- 2012-07-18
- Target Recruit Count
- 47
- Registration Number
- NCT00005868
- Locations
- 🇳🇱
Leiden University Medical Center, Leiden, Netherlands
🇮🇹Istituto Nazionale per la Ricerca sul Cancro, Genoa (Genova), Italy
🇳🇱Groot Ziekengasthuis 's-Hertogenbosch, 's-Hertogenbosch, Netherlands
Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors
- First Posted Date
- 2003-05-19
- Last Posted Date
- 2013-08-23
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 168
- Registration Number
- NCT00003203
- Locations
- 🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States
🇨🇦British Columbia Children's Hospital, Vancouver, British Columbia, Canada
Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-05-16
- Last Posted Date
- 2013-09-05
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 6
- Registration Number
- NCT00005086
- Locations
- 🇺🇸
Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States
🇺🇸Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-05-07
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- Radiation Therapy Oncology Group
- Target Recruit Count
- 36
- Registration Number
- NCT00059761
- Locations
- 🇺🇸
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States
🇺🇸Albert Einstein Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸University of Florida Shands Cancer Center, Gainesville, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.